Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Terminated 4Completed 3Recruiting 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 28Myeloid 9Dermatologic 8Plasma cell 3Genitourinary 3Thoracic 2Lymphoid 2Gynecologic 2Classical hematology 2CNS 2Tumor-Agnostic 1Other neoplasm 1

Conditions

Multiple Myeloma 3Lymphoma, T-Cell, Cutaneous 1

Interventions

Dexamethasone 393Bortezomib 246Lenalidomide 222Cyclophosphamide 184Melphalan 168Calcium Dobesilate 119Peripheral Blood Stem Cell Transplantation 94fludarabine phosphate 89Thalidomide 82Filgrastim 74carfilzomib 70pomalidomide 68Granulocyte Colony-Stimulating Factor 63Busulfan 63Mycophenolic Acid 61daratumumab 58Whole-Body Irradiation 57ixazomib 54fludarabine 52Tacrolimus 52Prednisone 51Cyclosporine 50Antilymphocyte Serum 35dexamethasone acetate 32plerixafor 30Etoposide 30Methotrexate 29Radiotherapy 28dexamethasone 21-phosphate 27Doxorubicin 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Tretinoin × Plasma cell × Clear all
NCT02751255 2023-04-28

DARA/ATRA

Amsterdam UMC, location VUmc

Phase 1/2 Completed
60 enrolled
Plasma cell

Multiple Myeloma

NCT02401295 2017-02-23

ATRA, Celecoxib, and Itraconazole as Maintenance

University of Iowa

Phase 1 Completed
1 enrolled
Plasma cell

Multiple Myeloma

NCT00400556 2006-11-17

ATRA Plus G-CSF for Mobilization of Hematopoietic Stem and Progenitor Cells

Peter MacCallum Cancer Centre, Australia

Phase 1 Completed
6 enrolled
DermatologicLymphoidPlasma cell

Multiple Myeloma, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡